XIFAXAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Rifaximin.
Product ID | 68258-1107_6b55d24c-094e-4ff0-80af-494574378d75 |
NDC | 68258-1107 |
Product Type | Human Prescription Drug |
Proprietary Name | XIFAXAN |
Generic Name | Rifaximin |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2004-07-25 |
Marketing Category | NDA / NDA |
Application Number | NDA021361 |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | RIFAXIMIN |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Rifamycin Antibacterial [EPC],Rifamycins [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2004-07-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021361 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2004-07-25 |
Inactivation Date | 2019-11-27 |
Marketing Category | NDA |
Application Number | NDA021361 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2004-07-25 |
Inactivation Date | 2019-11-27 |
Marketing Category | NDA |
Application Number | NDA021361 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2004-07-25 |
Inactivation Date | 2019-11-27 |
Ingredient | Strength |
---|---|
RIFAXIMIN | 200 mg/1 |
SPL SET ID: | 8eba0d26-06de-4ceb-9f69-efadd0375633 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50090-2445 | XIFAXAN | rifaximin |
55154-6777 | XIFAXAN | rifaximin |
65649-301 | XIFAXAN | rifaximin |
65649-303 | XIFAXAN | rifaximin |
68151-4980 | XIFAXAN | rifaximin |
68258-1107 | XIFAXAN | RIFAXIMIN |
69189-0309 | XIFAXAN | rifaximin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XIFAXAN 78428755 2965332 Live/Registered |
ALFASIGMA S.P.A. 2004-06-02 |